Arix Bioscience Names Former Smith & Nephew Science Head As Non-Exec

(Alliance News) - Arix Bioscience PLC on Tuesday said Naseem Amin has been appointed as a non-executive director with immediate effect.

In addition, Arix said Franz Humer will be retiring from the board on the same date.

The investment firm said Amin will be a member of the Remuneration Committee.

Amin is currently chief executive of GMP-Orphan and a venture partner at Advent Life Sciences. He previously was chief scientific officer of FTSE 100-listed medical equipment firm Smith & Nephew PLC.

Arix shares were trading 2.5% lower in London on Tuesday afternoon at 112.10 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

Smith & Nephew